BRIEF published on 09/09/2026 at 08:35, 3 days 19 hours ago Un Brevet Européen pour Batten-1 Renforce sa Protection Batten-1 Maladie De Batten Brevet Européen Miglustat Protection
BRIEF published on 09/09/2026 at 08:35, 3 days 19 hours ago European Patent Secures Batten-1's Future in Juvenile Batten Disease Treatment Orphan Drug Designation Batten-1 Juvenile Batten Disease European Patent THX Pharma
BRIEF published on 09/09/2026 at 08:35, 3 days 19 hours ago A European Patent for Batten-1 Strengthens its Protection Batten-1 Batten Disease European Patent Miglustat Protection
BRIEF published on 09/09/2026 at 08:35, 3 days 19 hours ago Un brevet européen garantit l'avenir du Batten-1 dans le traitement de la maladie de Batten juvénile. Désignation De Médicament Orphelin Batten-1 Brevet Européen THX Pharma Maladie De Batten Juvénile
BRIEF published on 09/09/2026 at 08:25, 3 days 19 hours ago KENDRIS Expands Its Footprint in Luxembourg Local Expertise KENDRIS Expansion Luxembourg Services OEC License International Network
BRIEF published on 09/09/2026 at 08:25, 3 days 19 hours ago KENDRIS renforce sa présence au Luxembourg Réseau International Extension KENDRIS Services Luxembourgeois Licence OEC Expertise Locale
BRIEF published on 09/09/2026 at 08:05, 3 days 20 hours ago ENOGIA Reports 32% Revenue Growth in H1 2026 Revenue Growth Energy Transition ENOGIA EU Funding Turbomachinery
BRIEF published on 09/09/2026 at 08:05, 3 days 20 hours ago ENOGIA annonce une croissance de son chiffre d'affaires de 32 % au premier semestre 2026 Transition Énergétique Croissance Des Revenus ENOGIA Financement De L'UE Turbomachines
BRIEF published on 09/09/2026 at 08:05, 3 days 20 hours ago ENOGIA : Croissance et Résultats Positifs au 1er Semestre 2026 Résultats Financiers EBITDA ENOGIA Modules ORC Turbo4Transition
BRIEF published on 09/09/2026 at 08:05, 3 days 20 hours ago ENOGIA: Growth and Positive Results in the First Half of 2026 Financial Results EBITDA ENOGIA ORC Modules Turbo4Transition
Published on 09/12/2026 at 02:35, 1 day 1 hour ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 5 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 6 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 11 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 10 hours 15 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 20 hours 35 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 5 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 5 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 8 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 21 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 21 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 8 hours ago Availability of the 2026 Interim Financial Report
